Tag: visceral pain industry analysis

  • Comprehensive Visceral Pain Market Analysis 2024: Size, Share, And Key Trends

    Comprehensive Visceral Pain Market Analysis 2024: Size, Share, And Key Trends

    Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

    What is the Expected Growth Rate of the Visceral Pain Market from 2024 to 2033?

    The visceral pain treatment market will increase from $12.87 billion in 2023 to $13.84 billion in 2024, at a CAGR of 7.6%. This growth is linked to an aging population, increased chronic disease prevalence, and advancements in medical research.

    The visceral pain treatment market is projected to grow strongly, reaching $17.70 billion in 2028 with a CAGR of 6.3%. Growth is attributed to innovations in pain management, demand for non-invasive treatments, emerging markets, personalized medicine, and digital health solutions. Trends include a shift to multimodal pain management, alternative therapies, targeted therapies, the role of telemedicine, and AI in pain assessment.

    Claim Your Free Sample of the Global Visceral Pain Market Report Today!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=13950&type=smp

    What Key Factors Are Fueling the Growth of the Visceral Pain Market?

    The growing demand for analgesics is anticipated to boost the visceral pain market. Analgesics alleviate pain by blocking pain signals in the brain and can help manage visceral pain by targeting the nervous system. In December 2023, the CDC reported an increase in Buprenorphine prescriptions, rising from 16,011,239 in 2020 to 16,105,318 in 2021, reflecting a 0.59% increase. Therefore, the rising demand for analgesics is driving the visceral pain market.

    What Are the Major Segments of the Visceral Pain Market?

    1) By Drug Class: Calcium Channel Blockers, Nonsteroidal Anti-Inflammatory (NSAID), Other Drug Classes

    2) By Indications: Interstitial Cystitis, Crohn’s, Irritable Bowel, Chronic Prostatitis, Other Indications

    3) By End Users: Hospitals, Homecare, Specialty Clinics, Other End Users

    What New Trends Are Transforming the Visceral Pain Market?

    Companies in the visceral pain market are creating innovative treatments like NHE3 inhibitors. In April 2022, Ardelyx launched IBSRELA, targeting symptoms of irritable bowel syndrome with constipation.

    Order Now for Fast Delivery of Your Visceral Pain Market Report!

    https://www.thebusinessresearchcompany.com/report/visceral-pain-global-market-report

    Which Regions Are Driving Growth in the Visceral Pain Market?

    North America was the largest region in the visceral pain market in 2023. The regions covered in the visceral pain market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    The Visceral Pain Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the visceral pain market, its market share, and analyzes key competitors along with their market positions.

    The Table Of Content For The Visceral Pain Market Include

    1. Visceral Pain Market Executive Summary

    2. Visceral Pain Market Segments

    3. Visceral Pain Market Size And Template Market Growth Rate

    4. Key Visceral Pain Market Trends

    5. Major Visceral Pain Market Drivers

    ……

    25. Key Mergers And Acquisitions In The Visceral Pain Market

    26. Top Visceral Pain Companies

    27. Visceral Pain Market Opportunities And Strategies

    28. Visceral Pain Market, Conclusions And Recommendations

    29. Appendix

    Discover Related Reports by The Business Research Company:

    Neuropathic Pain Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/neuropathic-pain-global-market-report

    Joint Pain Injections Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/joint-pain-injections-global-market-report

    Virtual Payment (POS) Terminals Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/virtual-payment-pos-terminals-global-market-report

    Learn More About The Business Research Company

    The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Comprehensive Analysis On Size, Share, And Drivers Of The Visceral Pain Market

    Comprehensive Analysis On Size, Share, And Drivers Of The Visceral Pain Market

    The Business Research Company’s global market reports provide comprehensive analysis on the various markets in 27 industries across 60 geographies.

    Market Growth Overview

    • 2023 to 2024 Growth: The visceral pain treatment market is set to grow from $12.87 billion in 2023 to $13.84 billion in 2024, reflecting a compound annual growth rate (CAGR) of 7.6%.
    • Historic Growth Drivers: Aging population, increased chronic diseases, advances in medical research, expanded healthcare infrastructure, and rising awareness and diagnosis rates have driven past growth.

    Future Market Prospects

    • 2024 to 2028 Growth: The market size is projected to reach $17.70 billion by 2028, with a CAGR of 6.3%.
    • Future Growth Drivers: Technological innovations, growing demand for non-invasive treatments, emerging markets, personalized medicine, and digital health solutions will propel growth.

    View More On The Visceral Pain Market Report 2024 – https://www.thebusinessresearchcompany.com/report/visceral-pain-global-market-report

    Key Market Trends

    • Multimodal Pain Management: A shift towards combining various pain management techniques.
    • Alternative Therapies: Increased emphasis on non-traditional pain relief methods.
    • Targeted Therapies: Rise of treatments aimed at specific types of pain.
    • Telemedicine: Growing role in managing pain remotely.
    • Artificial Intelligence: Integration in pain assessment and treatment planning.

    Rising Demand for Analgesics

    • Buprenorphine Prescriptions: Significant increase in buprenorphine prescriptions, from 16,011,239 in 2020 to 16,105,318 in 2021, as documented by the CDC.
    • Role of Analgesics: These medications manage visceral pain by targeting the nervous system and modulating pain signals from internal organs.

    Major Market Players

    • Notable Companies: Walgreens Boots Alliance Inc., Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Mylan N.V., Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Perrigo Company PLC, Dr. Reddy’s Laboratories Ltd., Endo International PLC, Grünenthal GmbH, Glenmark Pharmaceuticals Limited, Hisamitsu Pharmaceutical Co. Ltd., Chromocell Corporation, Addex Therapeutics Ltd.

    Innovative Treatments: NHE3 Inhibitors

    • NHE3 Inhibitor Drug: Ardelyx launched IBSRELA in April 2022, targeting irritable bowel syndrome with constipation (IBS-C).
    • Mechanism: NHE3 inhibitors reduce abdominal pain by decreasing visceral hypersensitivity and intestinal permeability.

    Strategic Acquisitions

    • Jazz Pharmaceuticals and GW Pharmaceuticals: In February 2021, Jazz Pharmaceuticals acquired GW Pharmaceuticals for $7.2 billion.
    • Impact: The acquisition expanded Jazz’s portfolio with GW’s cannabinoid products, including Epidiolex, approved for chronic visceral pain syndromes.

    Market Segmentation

    • By Drug Class: Calcium Channel Blockers, NSAIDs, Other Drug Classes
    • By Indications: Interstitial Cystitis, Crohn’s, Irritable Bowel, Chronic Prostatitis, Other Indications
    • By End Users: Hospitals, Homecare, Specialty Clinics, Other End Users

    Regional Insights

    • North America: The largest region in the visceral pain market in 2023.

    The visceral pain treatment market is poised for significant growth, driven by technological advancements, increased demand for non-invasive treatments, and strategic acquisitions by major pharmaceutical companies. The integration of digital health solutions and artificial intelligence will further enhance pain management and patient outcomes in the coming years.

    Request A Sample Of The Global Visceral Pain Market Report 2024:
    https://www.thebusinessresearchcompany.com/sample_request?id=13950&type=smp